2 recruiting, 1 completed, 1 terminated. 4 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Recruiting 2, Completed 1, Terminated 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Hepatitis D: new trials by email Literature Review of Hepatitis D trials Research Report on Hepatitis D
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Antiviral Activity of a Monoclonal Hepatitis B Antibody: a Phase 1b, Open-label Trial in Individuals With Chronic Hepatitis D Infection HepB mAb19 - Hepatitis D, Chronic, Hepatitis B Chronic Infection | Phase 1 | Recruiting | Aarhus University Hospital | 15 | 2026-04-23 | 2026-05-28 |
| Study of GS-4321 in Healthy Participants and Participants With Chronic Hepatitis Delta Virus GS-4321, GS-4321 Placebo - Chronic Hepatitis Delta | Phase 1 / Phase 2 | Recruiting | Gilead Sciences | 200 | 2025-07-31 | 2026-08-27 |
| A Study to Assess the Safety, Tolerability and Pharmacokinetics of ABI-6250 in Healthy Participants ABI-6250, Placebo - Hepatitis Delta Virus, Hepatitis D | Phase 1 | Completed | Assembly Biosciences | 40 | 2025-01-31 | 2025-12-04 |
| Proof-of-concept Study Evaluating the Safety and Efficacy of EBP921 in Delta Hepatitis (HDV) EBP921 - Hepatitis D | Phase 1 | Terminated | Eiger BioPharmaceuticals | 3 | 2011-01-01 | 2016-08-08 |
Hepatitis D, Chronic (2) · Hepatitis (1)
Digestive System Diseases (4) · Hepatitis, Viral, Human (4) · Infections (4) · Liver Diseases (4) · RNA Virus Infections (4) · Virus Diseases (4) · Hepatitis (3) · Chronic Disease (2) · Disease Attributes (2) · Hepatitis, Chronic (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2)
Aarhus University Hospital (1) · Assembly Biosciences (1) · Eiger BioPharmaceuticals (1) · Gilead Sciences (1)
Germany (2) · United States (2) · Bulgaria (1) · Denmark (1) · Italy (1) · Moldova (1) · New Zealand (1) · Romania (1) · South Korea (1) · Taiwan (1) · Turkey (Türkiye) (1)
2025 (2)